Virucidal Activity of a GT-Rich Oligonucleotide against Herpes Simplex Virus Mediated by Glycoprotein B
Authors:
Open Access
- 15 May 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (10) , 4740-4747
Abstract
We have investigated the antiviral mechanism of a phosphorothioate oligonucleotide, ISIS 5652, which has activity against herpes simplex virus (HSV) in the low micromolar range in plaque reduction assays. We isolated a mutant that is resistant to this compound. Marker rescue and sequencing experiments showed that resistance was due to at least one of three mutations in the UL27 gene which result in amino acid changes in glycoprotein B (gB). Because gB has a role in attachment and entry of HSV, we tested the effects of ISIS 5652 at these stages of infection. The oligonucleotide potently inhibited attachment of virus to cells at 4°C; however, the resistant mutant did not exhibit resistance at this stage. Moreover, a different oligonucleotide with little activity in plaque reduction assays was as potent as ISIS 5652 in inhibiting attachment. Similarly, ISIS 5652 was able to inhibit entry of preattached virions into cells at 37°C, but the mutant did not exhibit resistance in this assay. The mutant did not attach to or enter cells more quickly than did wild-type virus. Strikingly, incubation of wild-type virus with 1 to 2 μM ISIS 5652 at 37°C led to a time-dependent, irreversible loss of infectivity (virucidal activity). No virucidal activity was detected at 4°C or with an unrelated oligonucleotide at 37°C. The resistant mutant and a marker-rescued derivative containing its gB mutations exhibited substantial resistance to this virucidal activity of ISIS 5652. We hypothesize that the GT-rich oligonucleotide induces a conformational change in gB that results in inactivation of infectivity.Keywords
This publication has 33 references indexed in Scilit:
- Herpesvirus Entry: an UpdateJournal of Virology, 2003
- T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1995
- Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidineAntiviral Research, 1995
- A Genetic Selection Method for the Transfer of HSV-1 Glycoprotein B Mutations from Plasmid to the Viral Genome: Preliminary Characterization of Transdominance and Entry Kinetics of Mutant VirusesVirology, 1994
- G-Quartet Structures in Telomeric DNAAnnual Review of Biophysics, 1994
- Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionAntimicrobial Agents and Chemotherapy, 1993
- Entry of alphaherpesviruses into cellsSeminars in Virology, 1993
- The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapyAntiviral Research, 1991
- The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1Journal of General Virology, 1988
- Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1Journal of Molecular Biology, 1988